These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35381495)

  • 1. Evaluation of one-year effectiveness of clobazam as an add-on therapy to anticonvulsant monotherapy in participants with epilepsy having uncontrolled seizure episodes: An Indian experience.
    Satishchandra P; Rathore C; Apte A; Kumar A; Mandal A; Chauhan D; Agadi J; Gurumukhani J; Asokan K; Venkateshwarlu K; Lingappa L; Sundaracharya NV; Jha SK; Ravat S; Vk S; Garg S; Shah SV; Alagesan S; Razdan S; Padhy U; Agarwal VK; Arora V; Menon B; Shetty S; Chodankar D
    Epilepsy Behav; 2022 May; 130():108671. PubMed ID: 35381495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of clobazam as add-on therapy in patients aged 50 years and older with drug-resistant epilepsy.
    Nagarajan E; Lynch TM; Frawley B; Bunch ME
    Neurol Sci; 2023 Aug; 44(8):2883-2888. PubMed ID: 36964317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study.
    Kamaşak T; Serdaroğlu E; Yılmaz Ö; Kılıç BA; Polat BG; Erdoğan I; Yücel Şen AD; Özen N; Durgut BD; Yıldız N; Özkan Kart P; Dilber B; Arslan EA; Şahin S; Topçu Y; Gencpinar P; Serin HM; Hız SA; Çarman KB; Dündar NO; Okuyaz Ç; Aydın K; Serdaroğlu A; Tekgül H; Cansu A
    Epilepsy Res; 2022 Aug; 184():106963. PubMed ID: 35749975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clobazam higher-evening differential dosing as an add-on therapy in refractory epilepsy.
    Thome-Souza S; Klehm J; Jackson M; Kadish NE; Manganaro S; Fernández IS; Loddenkemper T
    Seizure; 2016 Aug; 40():1-6. PubMed ID: 27281712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clobazam monotherapy in drug naïve adult patients with epilepsy.
    Mehndiratta MM; Krishnamurthy M; Rajesh KN; Singh G
    Seizure; 2003 Jun; 12(4):226-8. PubMed ID: 12763470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years.
    Conry JA; Ng YT; Kernitsky L; Mitchell WG; Veidemanis R; Drummond R; Isojarvi J; Lee D; Paolicchi JM;
    Epilepsia; 2014 Apr; 55(4):558-67. PubMed ID: 24580023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of clobazam as add-on antiepileptic drug in patients with epilepsy.
    Joshi R; Tripathi M; Gupta P; Gupta YK
    Indian J Med Res; 2014 Aug; 140(2):209-15. PubMed ID: 25297352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLB add-on treatment in patients with epileptic encephalopathy: a single center experience with long-term follow-up.
    Türkdoğan D; Öztürk G
    Acta Neurol Belg; 2022 Feb; 122(1):51-57. PubMed ID: 33782854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should substitution monotherapy or combination therapy be used after failure of the first antiseizure medication? Observations from a 30-year cohort study.
    Hakeem H; Alsfouk BAA; Kwan P; Brodie MJ; Chen Z
    Epilepsia; 2023 May; 64(5):1248-1258. PubMed ID: 36869855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of clobazam as add-on therapy in children with refractory focal epilepsy.
    da Silveira MR; Montenegro MA; Franzon RC; Guerreiro CA; Guerreiro MM
    Arq Neuropsiquiatr; 2006 Sep; 64(3B):705-10. PubMed ID: 17057871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure control and complications in patients switching from clobazam to clonazepam due to drug shortage.
    Fırat O; Çakan M; Demirkan K; Dericioğlu N
    Epilepsy Behav; 2024 Apr; 153():109690. PubMed ID: 38382407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: An interim subgroup analysis from a phase 3, long-term, open-label safety study.
    Segal EB; Tarquinio D; Miller I; Wheless JW; Dlugos D; Biton V; Cascino GD; Desai J; Hogan RE; Liow K; Sperling MR; Vazquez B; Cook DF; Rabinowicz AL; Carrazana E;
    Epilepsia; 2021 Jun; 62(6):1442-1450. PubMed ID: 33942315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clobazam: effect on frequency of seizures and safety profile in different subgroups of children with epilepsy.
    Klehm J; Thome-Souza S; Sánchez Fernández I; Bergin AM; Bolton J; Harini C; Kadish NE; Libenson M; Peters J; Poduri A; Rotenberg A; Takeoka M; Bourgeois B; Loddenkemper T
    Pediatr Neurol; 2014 Jul; 51(1):60-6. PubMed ID: 24830765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clobazam monotherapy for partial-onset or generalized-onset seizures.
    Arya R; Anand V; Garg SK; Michael BD
    Cochrane Database Syst Rev; 2014 Oct; (10):CD009258. PubMed ID: 25280512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of perampanel as early add-on treatment in patients with epilepsy and focal seizures in the routine clinical practice: Spain prospective study (PERADON).
    Abril Jaramillo J; Estévez María JC; Girón Úbeda JM; Vega López Ó; Calzado Rivas ME; Pérez Díaz H; García Martín G; Vila Herrero E; Chamorro-Muñoz M; Vázquez F; De la Fuente C; Redondo L; Peláez N; Santágueda P; Rodríguez Uranga JJ
    Epilepsy Behav; 2020 Jan; 102():106655. PubMed ID: 31812902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of clobazam as add-on therapy in brain tumor-related epilepsy.
    Brahmbhatt N; Stupp R; Bushara O; Bachman E; Schuele SU; Templer JW
    J Neurooncol; 2021 Jan; 151(2):287-293. PubMed ID: 33398534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clobazam in refractory childhood epilepsy.
    Kalra V; Seth R; Mishra D; Saha NC
    Indian J Pediatr; 2010 Mar; 77(3):263-6. PubMed ID: 20177827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clobazam as an add-on in the management of refractory epilepsy.
    Michael B; Marson AG
    Cochrane Database Syst Rev; 2008 Apr; (2):CD004154. PubMed ID: 18425899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Add-on trial of clobazam in intractable adult epilepsy with plasma level correlations.
    Guberman A; Couture M; Blaschuk K; Sherwin A
    Can J Neurol Sci; 1990 Aug; 17(3):311-6. PubMed ID: 2207887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.